Screening and characterization of human single-chain Fv antibody against β-amyloid peptide 40

被引:11
作者
Cai, J
Wang, SZ [1 ]
Zhong, YW
Cheng, J
Ji, ZJ
Sheng, SL
Zhang, C
机构
[1] Beijing Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Beijing 100730, Peoples R China
[3] 302 Hosp PLA, Inst Infect Dis, Gene Therapy Res Ctr, Beijing 100039, Peoples R China
[4] Capital Univ Med Sci, Xuanwu Hosp, Beijing Res Lab Brain Aging, Beijing 100053, Peoples R China
关键词
Alzheimer's disease; amyloid-beta pepticle; phage display; single-chain antibody;
D O I
10.1097/00001756-200302100-00022
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Expression of single-chain variable fragment antibody on the surface of filamentous bacteriophage is widely used to make antibodies with pre-defined specificities. Using direct selection on solid phase-bound amyloid-beta 40 peptide, wich is a main pathogenic feature of Alzheimer's disease, we obtained single-chain Fv antibody with specific binding activity. The binding epitope of the antibody is located between amino acids 1 and 16 of the peptide antigen. DNA sequencing showed that the gene coding for the single chain Fv antibody consists of 768 bp, and the complementarity-determining regions were deduced.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 7 条
[1]
Reduced levels of amyloid β-peptide antibody in Alzheimer disease [J].
Du, Y ;
Dodel, R ;
Hampel, H ;
Buerger, K ;
Lin, S ;
Eastwood, B ;
Bales, K ;
Gao, F ;
Moeller, HJ ;
Oertel, W ;
Farlow, M ;
Paul, S .
NEUROLOGY, 2001, 57 (05) :801-805
[2]
Generation of auto-antibodies towards Alzheimer's disease vaccination [J].
Frenkel, D ;
Kariv, N ;
Solomon, B .
VACCINE, 2001, 19 (17-19) :2615-2619
[3]
Games D, 2000, ANN NY ACAD SCI, V920, P274
[4]
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum? [J].
Klein, WL ;
Krafft, GA ;
Finch, CE .
TRENDS IN NEUROSCIENCES, 2001, 24 (04) :219-224
[5]
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease [J].
Morgan, D ;
Diamond, DM ;
Gottschall, PE ;
Ugen, KE ;
Dickey, C ;
Hardy, J ;
Duff, K ;
Jantzen, P ;
DiCarlo, G ;
Wilcock, D ;
Connor, K ;
Hatcher, J ;
Hope, C ;
Gordon, M ;
Arendash, GW .
NATURE, 2000, 408 (6815) :982-985
[6]
Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse [J].
Schenk, D ;
Barbour, R ;
Dunn, W ;
Gordon, G ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Liao, ZM ;
Lieberburg, I ;
Motter, R ;
Mutter, L ;
Soriano, F ;
Shopp, G ;
Vasquez, N ;
Vandevert, C ;
Walker, S ;
Wogulis, M ;
Yednock, T ;
Games, D ;
Seubert, P .
NATURE, 1999, 400 (6740) :173-177
[7]
Characterization of murine immunoglobulin G antibodies against human amyloid-β1-42 [J].
Town, T ;
Tan, J ;
Sansone, N ;
Obregon, D ;
Klein, T ;
Mullan, M .
NEUROSCIENCE LETTERS, 2001, 307 (02) :101-104